Alessio Castronovo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessio Castronovo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Borghini
National Research Council, Institute of Clinical Physiology, 56124 Pisa, Italy
2 shared publications - Carolina Ferri
Department of Biology, University of Pisa, 56126 Pisa, Italy
2 shared publications - Fabio A. Recchia
Health Science Interdisciplinary Centre, Sant’Anna School of Advanced Studies, 56124 Pisa, Italy
2 shared publications - Federico Vozzi
CNR Institute of Clinical Physiology, 56124 Pisa, Italy
2 shared publications - Lorenzo Fontanelli
Health Science Interdisciplinary Centre, Sant’Anna School of Advanced Studies, Pisa, Italy
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 13 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 780
iPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease
Endothelial cells (ECs) regulate vascular homeostasis, and their dysfunction is a key driver of many cardiovascular and cerebrovascular diseases. Human-induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) provide access to patient-specific vascular cells that can be directed toward arterial, venous, or organotypic phenotypes, enabling personalized in vitro modeling of endothelial pathology. In this review, we discuss how patient-specific iPSC-ECs are used as predictive and personalized two- and three-dimensional models to dissect disease mechanisms and prioritize targeted therapies. We highlight some limitations of this methodology and outline future directions for integrating iPSC-EC-based assays into individualized treatment algorithms.
- 13 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 780
Top Cited PapersOpen AccessiPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease
Endothelial cells (ECs) regulate vascular homeostasis, and their dysfunction is a key driver of many cardiovascular and cerebrovascular diseases. Human-induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) provide access to patient-specific vascular cells that can be directed toward arterial, venous, or organotypic phenotypes, enabling personalized in vitro modeling of endothelial pathology. In this review, we discuss how patient-specific iPSC-ECs are used as predictive and personalized two- and three-dimensional models to dissect disease mechanisms and prioritize targeted therapies. We highlight some limitations of this methodology and outline future directions for integrating iPSC-EC-based assays into individualized treatment algorithms.
- Open Access
- 29 December 2025
- Published by MDPI AG in Preprints.org
iPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease
Endothelial cells (ECs) regulate vascular homeostasis, and their dysfunction is a key driver of many cardiovascular and cerebrovascular diseases. Human-induced pluripotent stem cell–derived endothelial cells (hiPSC-ECs) provide access to patient-specific vascular cells that can be directed toward arterial, venous, or organotypic phenotypes, enabling personalized in vitro modeling of endothelial pathology. In this review, we discuss how patient-specific iPSC-ECs are used as predictive and personalized two- and three-dimensional models to dissect disease mechanisms and prioritize targeted therapies, we highlight some limitations of this methodology, and outline future directions for integrating iPSC-EC–based assays into individualized treatment algorithms.
- 29 December 2025
- Published by MDPI AG in Preprints.org
Open AccessiPSC-Derived Endothelial Cells as Experimental Models for Predictive and Personalized Strategies in Cardiovascular and Cerebrovascular Disease
Endothelial cells (ECs) regulate vascular homeostasis, and their dysfunction is a key driver of many cardiovascular and cerebrovascular diseases. Human-induced pluripotent stem cell–derived endothelial cells (hiPSC-ECs) provide access to patient-specific vascular cells that can be directed toward arterial, venous, or organotypic phenotypes, enabling personalized in vitro modeling of endothelial pathology. In this review, we discuss how patient-specific iPSC-ECs are used as predictive and personalized two- and three-dimensional models to dissect disease mechanisms and prioritize targeted therapies, we highlight some limitations of this methodology, and outline future directions for integrating iPSC-EC–based assays into individualized treatment algorithms.